Nosis Bio SVP, Research & Development to chair session on Next Generation RNA technologies at the Annual RNA Leaders Congress

We’re proud to announce that Nosis Bio’s Senior Vice President of Research & Development, Dr. Denis Drygin, will be chairing a key session on Next Generation RNA Technologies at the annual RNA Leaders Congress. This conference is one of the foremost gatherings for leaders in RNA research, focusing on the latest innovations and advancements that are shaping the future of RNA therapeutics.

In this session, Denis will guide discussions on the evolving landscape of RNA therapeutics, with a focus on groundbreaking developments in RNA drug delivery, RNA payload design, and the transition from lab to clinic.

This session will bring together thought leaders, innovators, and researchers from across the RNA field to discuss the breakthroughs poised to redefine medicine. As a pioneering force in RNA technology, Nosis Bio is excited to help drive these conversations forward, sharing our own experiences and vision for a future where RNA medicines are more precise, accessible, and impactful.
‍

Stay tuned for more insights from the RNA Leaders Congress as we continue to champion the development of next-generation RNA therapies.

‍